Meeting slides Multiple Myeloma 2007

FRIDAY, APRIL 20, 2007

 

Registration opens at 10:00 am. Lunch buffet available from 12:00
13.30                         Welcome & Opening words - J San Miguel  JL Harousseau  M Aapro
13.35 – 13.50             Imid’s: Lonilamide and thalidomide - JL Harousseau 
13.55 – 14.10             Proteasome inhibitor bortezomib for the treatment of multiple myeloma. P Sonneveld
14.15 – 14.35             Agents in the pipeline for the treatment of multiple myeloma. - M Engelhardt

Session I: Biology and prognostic Indicators - Chair: H Avet-Loiseau

 

14.40 – 15.00             Understanding the biology of multiple myeloma - P Liebisch
15:10 – 15:30             Differentiating MGUS and MM - J Blade
15.40 – 16.00             New prognostic factors and staging systems in MM - H Avet-Loiseau, FR
16.10 – 16.45             Break

 

Session II: Treatment options - Chair: M Boccadoro

 

16:45 – 17:10             Treatment options for young patients newly diagnosed with Multiple Myeloma - J San Miguel
17:20 – 17:45             Treatment options for elderly or frail patients newly diagnosed with Multiple Myeloma - M Boccadoro
17:55 - 18:20             Treatment of relapsed and refractory myeloma - M. Attal
18.30                         Closure of the day.
20.00                         Depart from the hotel lobby to Gala Dinner.

 

SATURDAY APRIL 21, 2007

 

Session III: Disease or Treatment complications - Chair: JL Harousseau 

 

09:00 – 09:20             Overcoming thrombosis in MM patients -A. Palumbo
09:30 – 09.50             Bone integrity and MM patients - O Hjertner
10:00 – 10:30             COFFEE BREAK

 

Session IV: Stem cell transplantation - Chaired: M Aapro 

 

10.30 – 10:45             The role and timing of autologous stem cell transplantation - JL Harousseau
10.50 – 11:05             The role and timing of allogeneic stem cell transplantation - A Perez-Simon

 

Session V: Today and tomorrow - Chair: J. San Miguel  JL Harousseau 

 

11:15 - 11.35             What should we learn from molecular genetics and gene arrays - G Morgan
11:45 – 12:05             What is important for the patients - A Patient
12:10 – 12:40             Expectations for the future - J San Miguel and JL Harousseau

 

A panel discussion led by J San Miguel and JL Harousseau, addressing the on-going and future studies to improve upon present results

 

12:45 – 13.00             Learning Assessments:
13.00 - 14.00             Lunch-buffet and certificate delivery